Muhammad Arfan

Dr. Muhammad Arfan


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
HNHammad Nasir
Hammad Nasir
NANaeem Abbas
Naeem Abbas
MAMuhammad Arfan
Muhammad Arfan
UAUsman Aftab
Usman Aftab
ARAli Rafi
Ali Rafi
Muhammad LatifMuhammad Latif
Muhammad Latif
In present studies, six Schiff bases were prepared, characterized and evaluated for their anti-tumor activity against the colorectal cancer cell line SW-480. The test compounds were characterized by various physico-chemical techniques such as M. P., TLC, UV, FT-IR, elemental analysis, 1H-NMR spectroscopy etc. and investigated for their non-covalent DNA binding potential. The electronic absorption and hydrodynamic studies expressed strong complementary evidence that the Schiff bases are binding between the narrow walls of the helical DNA grooves and were stabilized via electrostatic interactions through groove binding as the dominant binding mode. Moreover, these studies also revealed that the tested compound had significant non-covalent binding to chicken (ck) blood ds-DNA at blood pH (7.4) and body temperature 310 K: the calculated values of standard Gibbs free energy changes (ΔG = −RT ln Kf) for all compounds were negative which manifested the spontaneity of binding for all compounds. The cytotoxicity of the compounds was found through triplicate testing and the O. D. values were compared to find the percentage viability of the cells. The IC50 values of the compounds were estimated through dose-dependent curves. HSB3, HSB4 and HSB1 showed relatively potent anti-cancer activity with IC50 values of 7.0913 μg mL−1, 17.1469 μg mL−1 and 17.5254 μg mL−1, respectively. The same compounds had also exhibited relatively better ds-DNA binding efficacy with binding constant values (9.1 × 105, 3.5 × 105 and 5.13 × 104 respectively).

7 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NANaeem Ahmed
Naeem Ahmed
SASabahat Asif
Sabahat Asif
MAMuhammad Arfan
Muhammad Arfan
Qaiser MahmoodQaiser Mahmood
Qaiser Mahmood
AIAmjad Islam
Amjad Islam
MZMuhammad Zia
Muhammad Zia
Obesity is a source of significant pathologies and deadly diseases, including heart disease, diabetes, and cancer. One of the most intriguing strategies in the hunt for new anti-obesity medications is the inhibition of pancreatic lipase (PL). This study presents a novel application of short α and β-mixed peptides as pancreatic lipase inhibitors. These peptides were synthesized in the solution phase and characterized using FTIR and 1H-NMR. L-proline is present in a high percentage of natural anti-lipase peptides and was used as a β-amino acid in this study to enhance anti-lipase activity and proteolytic stability. Moreover, L-α-proline was converted to β-amino acid derivatives using the Arndt–Eistert method with the advantage of stereo control at the α-carbon. The synthesized peptides with anti-lipase activity are N-Boc-β-Pro-Gly-OBz (93%), N-Boc-O-Bz-Tyr-β-Pro-β-Pro-Gly-OBz (92%), N-Boc-O-Bz-Tyr-β-Pro-COOH (91%), N-Boc-Phe-β-Pro-OCH3 (90%), and N-Boc-O-Bz-Tyr-β-Pro-OCH3 (89%). These peptides may function as lead molecules for further modification to more significant molecules, which can help control obesity.

1 February 2020 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MAMuhammad Arfan
Muhammad Arfan
ATA. Tahira
A. Tahira
AMA. Mannan
A. Mannan
TFT. Fatima
T. Fatima
–A simple trituration method for the synthesis of 2-substituted benzothiazoles derived from N-protected amino acids and 2-aminothiophenol using molecular iodine as a mild Lewis acid catalyst has been proposed. The reaction occurs in one step for 20–25 min in solve-free conditions and provides the target products in excellent yields.

27 July 2026 in Journal of Saudi Chemical Society
Verified
Journal Article
Open access
PDF file
NANaeem Abbas
Naeem Abbas
MAMuhammad Arfan
Muhammad Arfan
MIMudassir Iqbal
Mudassir Iqbal
YIYasir Iqbal
Yasir Iqbal
UAUsman Aftab
Usman Aftab
MEMuhammad Fahad Ehsan
Muhammad Fahad Ehsan
β-carboline alkaloid-based ligand, 2,3,4,9-tetrahydro-β-carboline-3-carboxylic acid (NZ1), a recognized active metabolite in plants, animals, and humans, was synthesized and subsequently complexed with Ni(II) and Cu(II) ions to yield the new mononuclear metallocarboxylate complexes NZ2 and NZ3 respectively. The structural characterization confirmed the successful coordination of the central metal atom to the ligand framework. The non-covalent interactions of these compounds with the chicken blood ds-DNA were investigated through UV–visible absorption, fluorescence emission spectroscopy, viscosity measurements and molecular docking studies. Photophysical changes observed under UV-Visible and Fluorescence spectroscopic studies clearly predicted the presence of dominant minor groove binding as all compounds exhibited hyperchomic effect without any remarkable shift in UV absorption maxima and progressive quenching of intrinsic fluorescence intensities upon addition of ds-DNA without notable shifts in emission maxima. While viscometric measurements and molecular docking studies for all compounds confirmed dominant minor groove binding interaction rather than classical intercalation. Notably, NZ3 demonstrated the highest DNA affinity as followed by NZ2 and NZ1. In antioxidant assays, metal complexation significantly enhanced the free-radical scavenging activity and NZ3 complex demonstrated superior efficacy. The anticancer potential against triple-negative breast cancer cell lines (MDA-MB-231) was assessed by MTT assay and revealed dose-dependent decline in cell viability. The IC₅₀ values were > 200 µg/mL for NZ1, 123.46 µg/mL for NZ2, and 10.50 µg/mL for NZ3, establishing NZ3 (Cu(II) complex) as the most potent candidate, causing a marked reduction in cell viability (7.46 ± 3.15% at 200 µg/mL). These findings demonstrated that Ni(II) and Cu(II) coordination significantly improved the DNA binding, antioxidant, and anticancer activities of the 2,3,4,9-tetrahydro-1 H-β-carboline-3-carboxylic acid ligand NZ3 as a promising scaffold for DNA-targeting and therapeutic applications.

4 November 2026 in RSC Advances
Verified
Journal Article
Open access
NANaeem Abbas
Naeem Abbas
MAMuhammad Arfan
Muhammad Arfan
YIYasir Iqbal
Yasir Iqbal
MIMudassir Iqbal
Mudassir Iqbal
NANaeem Ahmed
Naeem Ahmed
MGMansour K. Gatasheh
Mansour K. Gatasheh
Engineering neurotransmitter-inspired, biolabile Mg( ii )/Ca( ii ) metallocarboxylates of N -phthaloyl- γ -aminobutyric acid as prodrug candidates for anticancer application.

26 August 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NANaeem Ahmed
Naeem Ahmed
FRFakhira Razzaq
Fakhira Razzaq
MAMuhammad Arfan
Muhammad Arfan
MGMansour K. Gatasheh
Mansour K. Gatasheh
HNHammad Nasir
Hammad Nasir
HHHamna Hafeez
Hamna Hafeez
Over the last decades, the increased incidence of metabolic disorders, such as type two diabetes and obesity, has motivated researchers to investigate new enzyme inhibitors. Inhibition of the α-amylase enzyme is one therapeutic approach in lowering glucose levels in the blood to manage diabetes mellitus. The objective of this study was to synthesize short α-/β-mixed peptides in the solution phase. The Boc-protected α-L-leucine was converted to β-analogue by using Arndt–Eistert synthesis with the advantage of no racemization and retention of configuration. Three novel short peptides were successfully synthesized: N(Boc)-Gly-β-Leu–OCH3(14), N(Boc)-O(Bz)α-Ser-β-Leu–OCH3(16), and N(Boc)-O(Bz)-α-Tyr-α-Gly-β-Leu–OCH3(17), characterized by FTIR and 1H NMR analysis. The synthesized peptide 16 showed highest inhibitory activity (45.22%) followed by peptide 14 (18.51%) and peptide 17 (17.05%), respectively. Intriguingly, peptide 16 showed higher inhibition on α-amylase compared with other α-/β-mixed peptides.